Homepage
Medication Guide
Adverse Reactions of Sladelpar
Sladelpar is a novel peroxisome proliferator-activated receptor delta (PPARδ) agonist. Approved in the United States in 2024, it is indicated for the treatment of adult patients with primary biliary c...
507
Tuesday, December 30th, 2025, 09:38
What Are the Purchase Channels for Voranidenib (Voranigo)?
Voranidenib (Voranigo) is a novel targeted therapy approved for marketing by the U.S. Food and Drug Administration (FDA) in 2024. It is indicated for the treatment of grade 2 gliomas (astrocytoma or o...
507
Tuesday, December 30th, 2025, 09:33
What are the Indications of Voranidenib (Voranigo)?
Voranidenib (Voranigo) is a novel oral targeted therapy, which was first approved for marketing in the United States in 2024. As a dual inhibitor of isocitrate dehydrogenase-1 (IDH1) and isocitrate de...
507
Tuesday, December 30th, 2025, 09:29
Dosage and Administration of Voranidenib (Voranigo)
Voranidenib (Voranigo) is an oral inhibitor of isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2). It is indicated for the treatment of adult patients and pediatric patients aged ...
506
Tuesday, December 30th, 2025, 09:24
Adverse Reactions of Pretomanid
Pretomanid is an oral nitroimidazooxazine antimycobacterial agent indicated for the treatment of pulmonary tuberculosis (TB) in adults with extensively drug-resistant (XDR) or multidrug-resistant (MDR...
507
Monday, December 29th, 2025, 11:04
What are the Precautions for Pretomanid Administration?
Pretomanid is an oral nitroimidazooxazine antimycobacterial agent. As part of a combination therapeutic regimen with bedaquiline and linezolid, it is specifically indicated for the treatment of specif...
504
Monday, December 29th, 2025, 11:03
Where to Purchase Lazertinib
Lazertinib is an oral kinase inhibitor for combined use with Amivantamab, offering a novel treatment option for patients with advanced non-small cell lung cancer (NSCLC) harboring specific epidermal g...
502
Monday, December 29th, 2025, 10:33
What are the Indications for Lazertinib?
Lazertinib is an oral kinase inhibitor that received its first approval in the United States in 2024. In combination with Amivantamab, another medicinal product, it provides a novel treatment option f...
504
Monday, December 29th, 2025, 10:28
Dosage and Administration of Lazertinib, Recommended Dosage
Lazertinib is a kinase inhibitor indicated in combination with Amivantamab for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harbori...
504
Monday, December 29th, 2025, 10:11
Dosage and Administration, Recommended Dose of Flopropione Tablets (Cospanon)
Flopropione Tablets (Cospanon) is a medicine used to relieve spasms of the biliary tract, pancreas and urinary system. Clinically, it is commonly prescribed for biliary dyskinesia, cholelithiasis, cho...
506
Friday, December 26th, 2025, 14:50
21 / 207
2061 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved